NOT KNOWN FACTUAL STATEMENTS ABOUT PMTA 0 11

What's more, it addresses the FDA’s communications Together with the applicant, the retention of records that help the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may perhaps transfer ownership of the SE report back to a new applicant and electronic submission from the SE repo